Tech Company Financing Transactions

Limerick BioPharma Funding Round

OVP Venture Partners, Altitude Life Science Ventures and Arch Venture Partners invested in a $15 million Series C capital raise for Limerick BioPharma. The round was recorded on 7/15/2009.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

601 Gateway Blvd. 1050
South San Francisco, CA 94080
USA

Phone

(650) 742-0110

Website

www.limerickbio.com

Email Address

[email protected]

Overview

Limerick BioPharma is dedicated to developing compounds that, when used adjunctively with both marketed and investigational drugs, significantly improve the quality of patients' lives. Our compounds minimize toxic side effects at non-targeted vulnerable organs and tissue while maintaining or enhancing a drug's desired effects.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Wendye Robbins

        

Chief Financial Officer

Asha Rajagopal

        

Chief Scientific Officer

Ving Lee

        

VP - R & D

Michael Chang

        

Browse more venture capital transactions:

Prev: 7/15/2009: ProtonMedia venture capital transaction
Next: 7/15/2009: Bio Architecture Lab venture capital transaction

Share this article

Where The Data Comes From

We report on funding rounds that are announced publicly. VC investment data records on this site come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary